Renovaro Biosciences (RENB) Announces $10M in Equity Committed

Renovaro, Inc. (NASDAQ: RENB) announces that it has $10 million in additional equity committed at a price per share of $1.4726 and 10 percent warrant coverage.

“We appreciate confidence in the Company demonstrated by the investors,” said the Hon. Mark Dybul, MD, CEO. “We believe this is only the beginning. We are hopeful to be able to secure additional financing such as, but not limited to, long-term loans, grants and subsidies from various US and European institutions for which the Company is eligible – potentially worth tens of millions of dollars.”

You May Also Be Interested In

• Copart (CPRT) call put ratio 1.8 calls 1 put a share price up 3.9%
• Vance: we're not talking to Iran unless they stop shooting at ships
• OpenAI launches GPT-6 Astra for enterprise users today